Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands.

Vos LM, Oosterheert JJ, Kuil SD, Viveen M, Bont LJ, Hoepelman AIM, Coenjaerts FEJ.

J Clin Virol. 2019 Mar;112:20-26. doi: 10.1016/j.jcv.2019.01.007. Epub 2019 Jan 23.

PMID:
30708281
2.

Long-term expanding human airway organoids for disease modeling.

Sachs N, Papaspyropoulos A, Zomer-van Ommen DD, Heo I, Böttinger L, Klay D, Weeber F, Huelsz-Prince G, Iakobachvili N, Amatngalim GD, de Ligt J, van Hoeck A, Proost N, Viveen MC, Lyubimova A, Teeven L, Derakhshan S, Korving J, Begthel H, Dekkers JF, Kumawat K, Ramos E, van Oosterhout MF, Offerhaus GJ, Wiener DJ, Olimpio EP, Dijkstra KK, Smit EF, van der Linden M, Jaksani S, van de Ven M, Jonkers J, Rios AC, Voest EE, van Moorsel CH, van der Ent CK, Cuppen E, van Oudenaarden A, Coenjaerts FE, Meyaard L, Bont LJ, Peters PJ, Tans SJ, van Zon JS, Boj SF, Vries RG, Beekman JM, Clevers H.

EMBO J. 2019 Feb 15;38(4). pii: e100300. doi: 10.15252/embj.2018100300. Epub 2019 Jan 14.

3.

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.

Jacobino SR, Nederend M, Reijneveld JF, Augustijn D, Jansen JHM, Meeldijk J, Reiding KR, Wuhrer M, Coenjaerts FEJ, Hack CE, Bont LJ, Leusen JHW.

MAbs. 2018 Apr;10(3):453-462. doi: 10.1080/19420862.2018.1433974. Epub 2018 Mar 19.

4.

Neutrophil-mediated Suppression of Influenza-induced Pathology Requires CD11b/CD18 (MAC-1).

Tak T, Rygiel TP, Karnam G, Bastian OW, Boon L, Viveen M, Coenjaerts FE, Meyaard L, Koenderman L, Pillay J.

Am J Respir Cell Mol Biol. 2018 Apr;58(4):492-499. doi: 10.1165/rcmb.2017-0021OC.

PMID:
29141155
5.

The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.

Huijts SM, Coenjaerts FEJ, Bolkenbaas M, van Werkhoven CH, Grobbee DE, Bonten MJM; CAPiTA study team.

Clin Microbiol Infect. 2018 Jul;24(7):764-770. doi: 10.1016/j.cmi.2017.10.006. Epub 2017 Oct 16.

6.

Erratum to: Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases.

Gieselbach RJ, Muller-Hansma AH, Wijburg MT, de Bruin-Weller MS, van Oosten BW, Nieuwkamp DJ, Coenjaerts FE, Wattjes MP, Murk JL.

J Neurol. 2017 Aug;264(8):1833-1836. doi: 10.1007/s00415-017-8557-1. No abstract available.

PMID:
28711999
7.

Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases.

Gieselbach RJ, Muller-Hansma AH, Wijburg MT, de Bruin-Weller MS, van Oosten BW, Nieuwkamp DJ, Coenjaerts FE, Wattjes MP, Murk JL.

J Neurol. 2017 Jun;264(6):1155-1164. doi: 10.1007/s00415-017-8509-9. Epub 2017 May 23. Review. Erratum in: J Neurol. 2017 Jul 15;:.

PMID:
28536921
8.

Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection.

Jacobino SR, Nederend M, Hennus M, Houben ML, Ngwuta JO, Viveen M, Coenjaerts FEJ, Hack CE, van Neerven RJJ, Graham BS, Bont L, Leusen JHW.

J Allergy Clin Immunol. 2016 Nov;138(5):1477-1480.e5. doi: 10.1016/j.jaci.2016.06.001. Epub 2016 Jun 16. No abstract available.

PMID:
27448445
9.

Rapid and generic identification of influenza A and other respiratory viruses with mass spectrometry.

Majchrzykiewicz-Koehorst JA, Heikens E, Trip H, Hulst AG, de Jong AL, Viveen MC, Sedee NJ, van der Plas J, Coenjaerts FE, Paauw A.

J Virol Methods. 2015 Mar;213:75-83. doi: 10.1016/j.jviromet.2014.11.014. Epub 2014 Dec 8.

10.

Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness.

Zlateva KT, de Vries JJ, Coenjaerts FE, van Loon AM, Verheij T, Little P, Butler CC, Goossens H, Ieven M, Claas EC; GRACE Study Group.

Eur Respir J. 2014 Jul;44(1):169-77. doi: 10.1183/09031936.00172113. Epub 2014 May 29. Erratum in: Eur Respir J. 2014 Aug;44(2):556.

11.

Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.

Schijf MA, Lukens MV, Kruijsen D, van Uden NO, Garssen J, Coenjaerts FE, Van't Land B, van Bleek GM.

PLoS One. 2013 Nov 26;8(11):e81695. doi: 10.1371/journal.pone.0081695. eCollection 2013.

12.

A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.

Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA.

PLoS One. 2013 Aug 12;8(8):e71072. doi: 10.1371/journal.pone.0071072. eCollection 2013.

13.

The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Tan L, Coenjaerts FE, Houspie L, Viveen MC, van Bleek GM, Wiertz EJ, Martin DP, Lemey P.

J Virol. 2013 Jul;87(14):8213-26. doi: 10.1128/JVI.03278-12. Epub 2013 May 22.

14.

Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.

Kruijsen D, Einarsdottir HK, Schijf MA, Coenjaerts FE, van der Schoot EC, Vidarsson G, van Bleek GM.

J Virol. 2013 Jul;87(13):7550-7. doi: 10.1128/JVI.00493-13. Epub 2013 May 1.

15.

Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology.

Tan L, Lemey P, Houspie L, Viveen MC, Jansen NJ, van Loon AM, Wiertz E, van Bleek GM, Martin DP, Coenjaerts FE.

PLoS One. 2012;7(12):e51439. doi: 10.1371/journal.pone.0051439. Epub 2012 Dec 7.

16.

Opioid receptors control viral replication in the airways.

Salimi V, Hennus MP, Mokhtari-Azad T, Shokri F, Janssen R, Hodemaekers HM, Rygiel TP, Coenjaerts FE, Meyaard L, Bont L.

Crit Care Med. 2013 Jan;41(1):205-14. doi: 10.1097/CCM.0b013e31826767a8.

PMID:
23222260
17.

No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOP-based primers.

Zlateva KT, Coenjaerts FE, Crusio KM, Lammens C, Leus F, Viveen M, Ieven M, Spaan WJ, Claas EC, Gorbalenya AE.

Arch Virol. 2013 Jan;158(1):251-5. doi: 10.1007/s00705-012-1487-4. Epub 2012 Sep 28.

PMID:
23053517
18.

Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.

Schijf MA, Kruijsen D, Bastiaans J, Coenjaerts FE, Garssen J, van Bleek GM, van't Land B.

J Virol. 2012 Nov;86(21):11472-82. doi: 10.1128/JVI.06708-11. Epub 2012 Aug 15.

19.

CD200 receptor controls sex-specific TLR7 responses to viral infection.

Karnam G, Rygiel TP, Raaben M, Grinwis GC, Coenjaerts FE, Ressing ME, Rottier PJ, de Haan CA, Meyaard L.

PLoS Pathog. 2012;8(5):e1002710. doi: 10.1371/journal.ppat.1002710. Epub 2012 May 17.

20.

Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.

Kruijsen D, Schijf MA, Lukens MV, van Uden NO, Kimpen JL, Coenjaerts FE, van Bleek GM.

Vaccine. 2011 Mar 24;29(15):2730-41. doi: 10.1016/j.vaccine.2011.01.087. Epub 2011 Feb 19.

PMID:
21316502
21.

A sensitive assay for virus discovery in respiratory clinical samples.

de Vries M, Deijs M, Canuti M, van Schaik BD, Faria NR, van de Garde MD, Jachimowski LC, Jebbink MF, Jakobs M, Luyf AC, Coenjaerts FE, Claas EC, Molenkamp R, Koekkoek SM, Lammens C, Leus F, Goossens H, Ieven M, Baas F, van der Hoek L.

PLoS One. 2011 Jan 24;6(1):e16118. doi: 10.1371/journal.pone.0016118.

22.

Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.

Kruijsen D, Bakkers MJ, van Uden NO, Viveen MC, van der Sluis TC, Kimpen JL, Leusen JH, Coenjaerts FE, van Bleek GM.

J Immunol. 2010 Dec 1;185(11):6489-98. doi: 10.4049/jimmunol.1002645. Epub 2010 Oct 22.

23.

Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infection.

van de Pol AC, Wolfs TF, van Loon AM, Tacke CE, Viveen MC, Jansen NJ, Kimpen JL, Rossen JW, Coenjaerts FE.

J Clin Microbiol. 2010 Oct;48(10):3569-74. doi: 10.1128/JCM.00097-10. Epub 2010 Jul 21.

24.

Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community.

Houben ML, Coenjaerts FE, Rossen JW, Belderbos ME, Hofland RW, Kimpen JL, Bont L.

J Med Virol. 2010 Jul;82(7):1266-71. doi: 10.1002/jmv.21771.

PMID:
20513094
25.

Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction.

Meerhoff TJ, Houben ML, Coenjaerts FE, Kimpen JL, Hofland RW, Schellevis F, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2010 Apr;29(4):365-71. doi: 10.1007/s10096-009-0865-7. Epub 2010 Jan 29.

26.

Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion.

Chadjichristos CE, Scheckenbach KE, van Veen TA, Richani Sarieddine MZ, de Wit C, Yang Z, Roth I, Bacchetta M, Viswambharan H, Foglia B, Dudez T, van Kempen MJ, Coenjaerts FE, Miquerol L, Deutsch U, Jongsma HJ, Chanson M, Kwak BR.

Circulation. 2010 Jan 5;121(1):123-31. doi: 10.1161/CIRCULATIONAHA.109.867176. Epub 2009 Dec 21.

PMID:
20026782
27.

A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM, Kimpen JL, Rossen JW, Ulfman LH, Tacke CE, Viveen MC, Koenderman L, Wolfs TF, van Bleek GM.

J Virol. 2010 Mar;84(5):2374-83. doi: 10.1128/JVI.01807-09. Epub 2009 Dec 16.

28.

Escherichia coli bacteriuria in female adults is associated with the development of hypertension.

Meiland R, Geerlings SE, Stolk RP, Hoepelman AI, Peeters PH, Coenjaerts FE, Grobbee DE.

Int J Infect Dis. 2010 Apr;14(4):e304-7. doi: 10.1016/j.ijid.2009.05.015. Epub 2009 Aug 4.

29.

Lack of CD200 enhances pathological T cell responses during influenza infection.

Rygiel TP, Rijkers ES, de Ruiter T, Stolte EH, van der Valk M, Rimmelzwaan GF, Boon L, van Loon AM, Coenjaerts FE, Hoek RM, Tesselaar K, Meyaard L.

J Immunol. 2009 Aug 1;183(3):1990-6. doi: 10.4049/jimmunol.0900252. Epub 2009 Jul 8.

30.

Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node.

Lukens MV, Kruijsen D, Coenjaerts FE, Kimpen JL, van Bleek GM.

J Virol. 2009 Jul;83(14):7235-43. doi: 10.1128/JVI.00452-09. Epub 2009 May 6.

31.

Association between Escherichia coli bacteriuria and renal function in women: long-term follow-up.

Meiland R, Stolk RP, Geerlings SE, Peeters PH, Grobbee DE, Coenjaerts FE, Brouwer EC, Hoepelman AI.

Arch Intern Med. 2007 Feb 12;167(3):253-7.

PMID:
17296880
32.

The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium.

Coenjaerts FE, Hoepelman AI, Scharringa J, Aarts M, Ellerbroek PM, Bevaart L, Van Strijp JA, Janbon G.

FEMS Yeast Res. 2006 Jun;6(4):652-61.

33.

The sixth international conference on cryptococcus and cryptococcosis.

Coenjaerts FE.

FEMS Yeast Res. 2006 Mar;6(2):312-7. No abstract available.

34.

Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis.

van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J, Kimpen JL, Hoepelman AI, Geelen SP.

J Neuroimmunol. 2005 Mar;160(1-2):170-7.

PMID:
15710470
35.

O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration.

Ellerbroek PM, Lefeber DJ, van Veghel R, Scharringa J, Brouwer E, Gerwig GJ, Janbon G, Hoepelman AI, Coenjaerts FE.

J Immunol. 2004 Dec 15;173(12):7513-20.

36.

Dexamethasone downregulates Cryptococcus neoformans-induced vascular endothelial growth factor production: a role for corticosteroids in cryptococcal meningitis?

Hoepelman AI, Van der Flier M, Coenjaerts FE.

J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1431-2. No abstract available.

PMID:
15483473
37.

Cryptococcal capsular glucuronoxylomannan reduces ischaemia-related neutrophil influx.

Ellerbroek PM, Schoemaker RG, van Veghel R, Hoepelman AI, Coenjaerts FE.

Eur J Clin Invest. 2004 Sep;34(9):631-40.

PMID:
15379763
38.

Intrathecal production and secretion of vascular endothelial growth factor during Cryptococcal Meningitis.

Coenjaerts FE, van der Flier M, Mwinzi PN, Brouwer AE, Scharringa J, Chaka WS, Aarts M, Rajanuwong A, van de Vijver DA, Harrison TS, Hoepelman AI.

J Infect Dis. 2004 Oct 1;190(7):1310-7. Epub 2004 Aug 18.

PMID:
15346343
39.

Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium.

Ellerbroek PM, Ulfman LH, Hoepelman AI, Coenjaerts FE.

Cell Microbiol. 2004 Jun;6(6):581-92.

PMID:
15104598
40.

Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.

Meiland R, Geerlings SE, Langermann S, Brouwer EC, Coenjaerts FE, Hoepelman AI.

J Urol. 2004 Apr;171(4):1589-93.

PMID:
15017227
41.

Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators.

Ellerbroek PM, Walenkamp AM, Hoepelman AI, Coenjaerts FE.

Curr Med Chem. 2004 Jan;11(2):253-66. Review.

PMID:
14754421
42.

Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

van de Wetering JK, Coenjaerts FE, Vaandrager AB, van Golde LM, Batenburg JJ.

Infect Immun. 2004 Jan;72(1):145-53.

43.

Interference of Cryptococcus neoformans with human neutrophil migration.

Walenkamp AM, Ellerbroek P, Scharringa J, Rijkers E, Hoepelman AI, Coenjaerts FE.

Adv Exp Med Biol. 2003;531:315-39. Review. No abstract available.

PMID:
12916803
44.
45.

Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization.

Coenjaerts FE, Walenkamp AM, Mwinzi PN, Scharringa J, Dekker HA, van Strijp JA, Cherniak R, Hoepelman AI.

J Immunol. 2001 Oct 1;167(7):3988-95.

46.

Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis.

Lipovsky MM, Tsenova L, Coenjaerts FE, Kaplan G, Cherniak R, Hoepelman AI.

J Neuroimmunol. 2000 Nov 1;111(1-2):10-4.

PMID:
11063816
47.

Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader.

Walenkamp AM, Scharringa J, Schramel FM, Coenjaerts FE, Hoepelman IM.

J Microbiol Methods. 2000 Mar;40(1):39-45.

PMID:
10739341
48.

Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure.

Walenkamp AM, Chaka WS, Verheul AF, Vaishnav VV, Cherniak R, Coenjaerts FE, Hoepelman IM.

FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):309-18.

49.

Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40.

Verheule S, van Batenburg CA, Coenjaerts FE, Kirchhoff S, Willecke K, Jongsma HJ.

J Cardiovasc Electrophysiol. 1999 Oct;10(10):1380-9.

PMID:
10515563
50.

Adenovirus DNA replication in a reconstituted system.

Coenjaerts FE, van der Vliet PC.

Methods Enzymol. 1995;262:548-60. No abstract available.

PMID:
8594378

Supplemental Content

Loading ...
Support Center